Biosimilars Implementation in the US: A Five Year Review
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Moving ctDNA Utilization Beyond Predictive Biomarkers: The Next Frontier
Christian Rolfo, MD, PhD, MBA, Dr.hc
Biosimilars Implementation in the United States: Where Opportunities Remain
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Seven Years of Biosimilar Experience in the U.S., Where Untapped Value Remains
Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Seven Years of Biosimilar Experience in the U.S., Where Untapped Value Remains
Jorge J. García, PharmD, MS, MHA, MBA, FACHE
